It is the responsibility of Nasdaq’s Listing Qualifications (LQ) Team to review and approve companies applying to list securities ... initial listing requirements and fees, please take a few ...
In January 2025, the Securities and Exchange Commission (SEC) approved rule changes proposed by the New York Stock Exchange (NYSE) and NYSE ...
The company has now met both the minimum bid price and market value of listed securities requirements ... the company continues to meet all Nasdaq listing standards. Currently, INKT is trading ...
MiNK Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback